# Eucure (Beijing) Biopharma Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eucure-beijing-biopharma-co

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.eucure.com
- Total disclosed funding: $38M
- Latest round: Series B (Mar 28, 2018)
- Investors on record: 4

## About

Founded in 2016 and based in Beijing, China, Eucure (Beijing) Biopharma Co., Ltd. is a biotechnology company that develops therapeutic antibodies for cancer treatment.

## Funding rounds

- Series B, Mar 28, 2018, $19M — CMB International Asset Management, 3E Bioventures Capital
- Series A, Jun 1, 2017, $10M — BVCF Capital, SDIC Venture Capital
- Series A, Dec 31, 2016, $8.6M — BVCF Capital, SDIC Venture Capital

## Investors

- BVCF Capital — Series A
- SDIC Venture Capital (https://capitalatlas.ai/funds/sdic-venture-capital) — Series A
- CMB International Asset Management (https://capitalatlas.ai/funds/cmb-international-asset-management) — Series B
- 3E Bioventures Capital (https://capitalatlas.ai/funds/3e-bioventures-capital) — Series B